Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAA Therapy for HCV-related Thrombocytopenia
NCT03169348Unknown
- Sponsor
- Assiut University
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sofosbuvir, daclatasvir and ledipasvir in hepatitis C (HCV), sponsored by Assiut University. Primary endpoint: Mean difference on the platelet count at 6 months. Status: unknown.
02
Drugs
sofosbuvirdaclatasvirledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03169348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03169348.